The endpoint of BBR-mediated metabolic reprogramming of alanine-supplemented HCC via GPT1 suppression blocked ATP production and thus resulted in induced apoptosis and suppressed HCC growth. This evidence concerns the gene GPT and hepatocellular carcinoma.